Adapting healthcare infrastructure for disease‐modification in early Alzheimer’s disease
Simon Rothwell, Enea Polotti, Christine Eksteen · 2025
Read Adapting healthcare infrastructure for disease‐modification in early Alzheimer’s disease by Simon Rothwell, Enea Polotti, Christine Eksteen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712648.txt.
Description
Simon Rothwell and co-authors published a research paper in 2025 on whether health systems in Europe are ready for the new drugs that slow early Alzheimer's disease. These drugs need proof of amyloid, drip sessions, and close scan follow-up. The team mapped current practice in four large European states plus the United Kingdom.
They reviewed public data, then spoke with neurologists and hospital managers. Scan capacity stood out as the tightest squeeze: too few machines and trained staff, with only a small share of scans set aside for this disease. Tests for amyloid also varied, with spinal fluid tests more common than costly scans. The authors urge better use of scan time to widen access.
Catalog record
| CREATOR | Simon Rothwell, Enea Polotti, Christine Eksteen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |